Priority 2030: we are heading for technological leadership

On March 15, a meeting of the Council of the Priority 2030 program was held in Moscow. Together with Ogarev Moscow State University, they reported on the results achieved and presented an updated development program aimed at achieving technological leadership.

"We continue to strengthen scientific and educational cooperation with the university within the framework of the Priority 2030 program. We are aware of our responsibility to society and are ready to share resources with our partner in order to jointly bring the Russian pharmaceutical industry to a new level. Our goal is to provide patients with effective and affordable medicines based on cutting–edge scientific achievements," said Peter Bely, Chairman of the Board of Directors of PROMOMED Group.

In 2024, with the support of the Company and the Head of the Republic of Mordovia, the Federal Center for the Development of Biotechnology and Medicine was launched at the university. Three laboratories equipped with modern equipment have been opened here, where new biotechnological products, including genetically engineered ones, are being created. At the request of the PROMOMED Group, the center's young scientists created a reporter cell line to evaluate the specific activity of a new anti-tumor drug based on monoclonal antibodies. And this is just the beginning! 

"The university is now a powerful driver of our economy. In the coming period, we will continue to work in the field of high-tech pharmaceuticals, fiber optics, and, of course, everything related to electrical engineering and cable products. The most important thing is science, which now makes it possible not to order abroad: this is especially true for pharmaceuticals and those studies that we used to depend on," said Artem Zdunov, Head of the Republic of Mordovia.

1. Photo: source priority2030.ru